Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,779
datasets available to search
ShareScore release 0.9.0
Dataset results
1,779 results for “Hodgkin lymphoma”
Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00110149. IPD Sharing: NO. Countries: 1. Publications: 0.
High-Dose vs Standard Ergocalciferol for Vitamin D Normalization in Aggressive Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT07366450. IPD Sharing: NO. Countries: 1. Publications: 0.
Agatolimod Sodium, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Recurrent or Refractory Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT00438880. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clofarabine and Rituximab in Treating Patients With Relapsed Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT00691652. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Brentuximab Vedotin (Recombinant) for IV Infusion - Special Drug Use Surveillance (All-case Surveillance) "Relapsed or Refractory CD30+ Hodgkin's Lymphoma or Anaplastic Large Cell Lymphoma"
ClinicalTrials.gov study NCT02139592. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of Brentuximab Vedotin in Adults With Hodgkin's Lymphoma
ClinicalTrials.gov study NCT05100056. IPD Sharing: YES. Countries: 1. Publications: 0.
Observation in Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma Treated on Clinical Trial CAN-NCIC-LY9
ClinicalTrials.gov study NCT00400907. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Safety and Efficacy Study of Immunotherapy With Rituximab and Interleukin-2 in Patients With Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00994643. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Rituximab and Cyclophosphamide Followed by Vaccine Therapy in Treating Patients With Relapsed Hodgkin Lymphoma
ClinicalTrials.gov study NCT00134082. IPD Sharing: NO. Countries: 1. Publications: 0.
Detection and Quant of Differences in Hodgkin Lymphoma and Diffuse Large B-cell Lymphoma Using Positron Emission Tomography/Computed Tomography (PET/CT)
ClinicalTrials.gov study NCT01004718. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Analysis of Molecular Markers of Drug Resistance in Tumor Biopsies From Previously Untreated Aggressive Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00026910. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Pilot Study of Abbreviated Chemotherapy Based on Positron Emission Tomography (PET) Scan in Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00901303. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Lenalidomide With or Without Rituximab in Treating Patients With Progressive or Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Prolymphocytic Leukemia, or Non-Hodgkin Lymphoma Prev
ClinicalTrials.gov study NCT01419795. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Silicon Phthalocyanine 4 and Photodynamic Therapy in Stage IA-IIA Cutaneous T-Cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT01800838. IPD Sharing: Not stated. Countries: 1. Publications: 0.
APR-246 in Combination With Acalabrutinib or Venetoclax Based Therapy in Subjects With R/R Non Hodgkin Lymphomas (NHL)
ClinicalTrials.gov study NCT04419389. IPD Sharing: NO. Countries: 1. Publications: 0.
Doxorubicin (Doxil) Combined With Rituxan, Cyclophosphamide, Vincristine and Prednisone in Newly Diagnosed Aggressive Non-Hodgkin's Lymphomas
ClinicalTrials.gov study NCT00184002. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase I/II Trial of VELCADE & Gemcitabine for Patients With Relapsed or Refractory Aggressive B- and T-cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00290706. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clofarabine in Treating Patients With T-Cell or Natural Killer-Cell Non-Hodgkin's Lymphoma That Has Relapsed or Not Responded to Previous Treatment
ClinicalTrials.gov study NCT00416351. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Umbralisib and Pembrolizumab in Treating Patients With Relapsed or Refractory Classical Hodgkin Lymphoma
ClinicalTrials.gov study NCT03776864. IPD Sharing: NO. Countries: 1. Publications: 0.
Antineoplaston Therapy in Treating Patients With Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00003498. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.